Erin K. Brenner - Dec 3, 2021 Form 3 Insider Report for Pear Therapeutics, Inc. (PEARQ)

Role: Chief Product Dev. Officer
Signature: /s/ Stacie S. Aarestad, Attorney-in-fact
Stock symbol: PEARQ
Transactions as of: Dec 3, 2021
Transactions value $: $0
Form type: 3
Date filed: 12/7/2021, 04:10 PM
Next filing: Feb 18, 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No Securities Beneficially Owned. Exhibit 24 Power of Attorney filed herewith.